Inventor · disambiguated record
Sung Sup Park
Also filed as: PARK SUNG SUP
7 granted patents·1 pending application·83 citations·filing 1999–2020
80Inventor score
Files withKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY2PARK SUNG SUP2CLAVISTHERAPEUTICS INC1LG CHEMICAL LTD1SEOUL NAT UNIV R&DB FOUNDATION1
Top patents by PatentIndex Score
8 records- 0183US9359592B2Method for differentiation into retinal cells from stem cellsPARK SUNG SUP·Filed 2010·Granted Jun 7, 2016·6 cites·17 claims
- 0283US6458934B1Humanized antibody specific for human 4-1BBLG CHEMICAL LTD·Filed 1999·Granted Oct 1, 2002·73 cites·4 claims
- 0377US9200252B2Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising Wnt signaling pathway activatorsPARK SUNG SUP·Filed 2010·Granted Dec 1, 2015·3 cites·13 claims
- 0473US10570370B2Method for differentiation into retinal ganglion cells from stem cellsSEOUL NAT UNIV R&DB FOUNDATION·Filed 2015·Granted Feb 25, 2020·1 cites·33 claims
- 0555US11168302B2Method for differentiation into retinal ganglion cells from stem cellsCLAVISTHERAPEUTICS INC·Filed 2020·Granted Nov 9, 2021·0 cites·23 claims
- 0644US10765642B2Composition for preventing or treating muscle weakness-related diseases comprising sobrerolKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2016·Granted Sep 8, 2020·0 cites·10 claims
- 0741US2003096976A1Humanized antibodies LB-00503 and LB-00506 specific for human 4-1BB and pharmaceutical compositions comprising said humanized antibodiesFiled 2002·Application pending·0 cites
- 0839US9949960B2Pharmaceutical composition for preventing or treating muscle weakness-related diseases, containing butylpyridinium or derivative thereofKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2016·Granted Apr 24, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Sung Sup Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →